Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients.
He ChengGuopei LuoKaizhou JinZhiyao FanQiuyi HuangYitao GongJin XuXian-Jun YuChen LiuPublished in: Cancer medicine (2020)
KrasG12V mutation was associated with high circulating regulatory T cell levels, and both of them predicted worse prognosis in advanced pancreatic cancer patients.